Mironescu S G
Int J Cancer. 1978 Sep 15;22(3):304-14. doi: 10.1002/ijc.2910220314.
The present study was performed in order to determine whether type III transformed foci induced by N-methyl-N'-nitro-N-nitrosoguanidine originate from the small subpopulation of cells stimulated by the carcinogen to enter DNA synthesis. During the last 30 min of variable treatment periods using different doses of N-methyl-N'-nitro-N-nitrosoguanidine, administered alone or in association with the thymidine analogue, 5'-bromo-2'-deoxyuridine (0.98 x 10(-5)M), the density-inhibited monolayers of hamster embryo cells were exposed to fluorescent light and then assayed for abnormal growth patterns by the focus formation method. Mock-irradiated cultures as well as monolayers whose medium lacked N-methyl-N'-nitro-N-nitro-soguanidine, 5'-bromo-2'-deoxyuridine, or both, served as controls. The cytotoxicity of 5'-bromo-2'- deoxyuridine + N-methyl-N'-nitro-N-nitrosoguanidine + photolysis (BMP) protocol on confluent as well as logarithmically growing hamster embryo cells was estimated in single-cell survival experiments. Plating efficiency determinations have demonstrated that, unlike their actively growing counterparts, confluent hamster embryo cell monolayers are extremely resistant to the cytotoxic effects of the BMP protocol. The quantitative transformation assays indicated that: (1) in non-illuminated cultures addition of 5'-bromo-2'-deoxyuridine to carcinogen-containing medium does affect transformation frequency of hamster embryo cells in the sense that the incidence of type III foci did not subside at later intervals during the post-carcinogen administration period as it did in the absence of the analogue; (2) irradiation of N-methyl-N'-nitro-N-nitrosoguanidine and halogenated pyrimidine analogue-treated cultures with fluorescent light practically suppressed transformation; (3) analogue-added and analogue-removed experiments pointed out that the event(s) on which 5'-bromo-2'-deoxyuridine fluorescent light sensitization of morphological transformation largely depends, takes place between 5 and 15 h after N-methyl-N'-nitro-N-nitrosoguanidine administration, i.e., during the period of maximal carcinogen-stimulated DNA synthesis; and (4) neither fluorescent light nor 5'-bromo-2'-deoxyuridine, singly or in combination, were able to transform cultures of hamster embryo cells. These findings are strong indirect arguments for the concept that carcinogen-induced DNA synthesis and the initiation of transformed clones are causally related.
进行本研究是为了确定由N-甲基-N'-硝基-N-亚硝基胍诱导产生的III型转化灶是否起源于受致癌物刺激而进入DNA合成的小细胞亚群。在使用不同剂量的N-甲基-N'-硝基-N-亚硝基胍单独或与胸苷类似物5'-溴-2'-脱氧尿苷(0.98×10⁻⁵M)联合进行的可变处理期的最后30分钟内,将仓鼠胚胎细胞的密度抑制单层暴露于荧光下,然后通过灶形成法检测异常生长模式。模拟照射的培养物以及培养基中缺乏N-甲基-N'-硝基-N-亚硝基胍、5'-溴-2'-脱氧尿苷或两者的单层用作对照。在单细胞存活实验中评估了5'-溴-2'-脱氧尿苷+N-甲基-N'-硝基-N-亚硝基胍+光解(BMP)方案对汇合以及对数生长的仓鼠胚胎细胞的细胞毒性。平板效率测定表明,与活跃生长的对应物不同,汇合的仓鼠胚胎细胞单层对BMP方案的细胞毒性具有极强的抗性。定量转化分析表明:(1)在未照射的培养物中,向含致癌物的培养基中添加5'-溴-2'-脱氧尿苷确实会影响仓鼠胚胎细胞的转化频率,因为III型灶的发生率在致癌物给药后的后期间隔并未像在没有该类似物时那样下降;(2)用荧光照射N-甲基-N'-硝基-N-亚硝基胍和卤代嘧啶类似物处理的培养物实际上抑制了转化;(3)添加类似物和去除类似物的实验指出,5'-溴-2'-脱氧尿苷对形态转化的荧光敏化在很大程度上所依赖的事件发生在N-甲基-N'-硝基-N-亚硝基胍给药后5至15小时之间,即在致癌物刺激的DNA合成的最大时期;(4)单独或联合使用荧光或5'-溴-2'-脱氧尿苷都不能使仓鼠胚胎细胞培养物发生转化。这些发现是对致癌物诱导的DNA合成与转化克隆的起始存在因果关系这一概念的有力间接论证。